- ►annals.org JH Gurwitz, JM Gore, RJ Goldberg, HV … - Annals of internal medicine, 1998 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Background: The efficacy of thrombolytic therapy in reducing mortality from ... Cited by 159 - Related articles - BL Direct - All 8 versions
- ►ahajournals.org JM Gore, CB Granger, ML Simoons, MA Sloan, … - Circulation, 1995 - Am Heart Assoc From the University of Massachusetts Medical Center, Worcester (JMG); Duke
University Medical Center, Durham, NC (CBG, RMC); Thoraxcenter-Erasmus
University, Rotterdam, Netherlands (MLS); University of Maryland School of ... Cited by 240 - Related articles - BL Direct - All 6 versions
- ►ahajournals.org LM Brass, JH Lichtman, Y Wang, JH Gurwitz, … - Stroke, 2000 - Am Heart Assoc From the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital,
New Haven, Conn (LMB, JHL, MJR, HMK); Neurology Service, VA Connecticut
Healthcare System, West Haven, Conn (LMB); Yale Stroke Program, Department ... Cited by 102 - Related articles - BL Direct - All 9 versions
MA Sloan, TR Price, CK Petito, AMY Randall, … - Neurology, 1995 - AAN Enterprises Article abstract-Parenchymatous intracerebral hemorrhage (ICH) is a serious,
infrequent complication of thrombolytic therapy for acute myocardial infarction.
We studied the clinical and radiologic features, manner of presentation, ... Cited by 73 - Related articles - BL Direct - All 3 versions
- ►ahajournals.org RW Smalling, C Bode, J Kalbfleisch, S Sen, P … - Circulation, 1995 - Am Heart Assoc Methods and Results The RAPID Trial was designed to test the hypothesis that
bolus administration of one or more dosage regimens of r-PA was superior to
standard-dose alteplase (TPA) in achieving infarct-related artery patency ... Cited by 177 - Related articles - BL Direct - All 5 versions
ML Simoons, AP Maggioni, G Knatterud, JD … - Lancet(British edition), 1993 - cat.inist.fr Individual risk assessment for intracranial haemorrhage during thrombolytic
therapy. ML SIMOONS, AP MAGGIONI, G KNATTERUD, JD LEIMBERGER ... Cited by 275 - Related articles - BL Direct - All 5 versions
SR Mehta, JW Eikelboom, S Yusuf - The Lancet, 2000 - Elsevier Seven trials, involving a total of 103 972 patients, met our inclusion criteria.
Bolus treatment was associated with an increased risk of intracranial
haemorrhage compared with infusion (0·8 vs 0·6%; odds ratio 1·25 [95% Cl ... Cited by 68 - Related articles - BL Direct - All 8 versions
F Van de Werf, CP Cannon, A Luyten, K … - American heart journal, 1999 - ncbi.nlm.nih.gov BACKGROUND: To evaluate the safety of several doses of a new thrombolytic, TNK
tissue-plasminogen activator (tPA), given as a single bolus to patients with
acute myocardial infarction. METHODS AND RESULTS: A total of 3235 patients ... Cited by 57 - Related articles - All 4 versions
- ►ahajournals.org [PDF] MA Sloan, CA Sila, KW Mahaffey, CB Granger, … - Circulation, 1998 - Am Heart Assoc Background—Limited information exists on risk factors for mortality after
thrombolysis-related intracranial hemorrhage. We wished to determine the
characteristics associated with 30-day mortality after thrombolysis-related ... Cited by 38 - Related articles - BL Direct - All 6 versions
- ►ahajournals.org SD Berkowitz, CB Granger, KS Pieper, KL Lee … - Circulation, 1997 - Am Heart Assoc Methods and Results We analyzed the baseline characteristics, outcomes, and
incidence of bleeding by location, severity, and treatment assignment among 41
021 patients in the GUSTO-I trial of thrombolysis for acute myocardial ... Cited by 133 - Related articles - BL Direct - All 6 versions
